Header image
![](/sites/default/files/styles/page_header_image/public/2023-07/foto_zahlavi_research_1.jpg?itok=p7pBtlZR)
Impact Factor Journals
IDH1/2 Mutations in Patients With Diffuse Gliomas.
Applied Immunohistochemistry and Molecular Morphology.
2021,
30(3),
178-183,
ISSN: 1541-2016,
PMID: 35262523,
A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment.
Cell Death & Disease.
2022,
13(3),
203,
ISSN: 2041-4889,
PMID: 35246527,
Global DNA methylation and increased DNMT3A expression in multiple myeloma patients.
Biomedical Papers - Olomouc.
2022,
ISSN: 1213-8118,
PMID: 35173353,
Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature.
BMC Gastroenterology.
2022,
22(1),
49,
ISSN: 1471-230X,
PMID: 35123392,
Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
Journal of the American Society of Nephrology.
2022,
33(5),
908-917,
ISSN: 1046-6673,
PMID: 35115327,
2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines.
International Journal of Molecular Medicine.
2022,
49(3),
31,
ISSN: 1107-3756,
PMID: 35039871,